Results. Linear regression analysis showed a significant association of WHR-based central obesity with forced expiratory volume in 1 s (FEV1) (beta = 9.04; p-value = .044) and forced vital capacity (FVC) (beta = -10.52; p-value = .012). Logistic regression analysis showed a significant increased risk of asthma attacks in 3 months with Asian WC-based central obesity [odds ratio (OR) = 6.31, 95% confidence interval (CI): 1.16-34.41]; emergency room (ER) visits with NIH WC-based GS-9973 chemical structure (OR = 5.15, 95% CI: 1.36-19.55) and Asian WC-based (OR = 18.72, 95% CI: 1.92-182.63) central obesity;
and hospitalization in 1 year with NIH WC-based (OR = 5.28, 95% CI: 1.28-21.84) and Asian WC-based (OR = 12.39, 95% CI: 1.29-119.53) central obesity. Conclusions. Our study shows that the Asian WC-based central obesity is a better predictor of asthma morbidity. The results of this study emphasize, when studying the relationship
between asthma control and obesity, the importance of selecting the proper definitions for asthma control or central obesity and appropriate cutpoints. Further study in this field using other asthma control and quality of life questionnaires is warranted.”
“Background: Bombesin (BOM) and gastrin releasing peptide (GRP) have been located to the lower urinary tract. However, there is a paucity of data demonstrating the impact FRAX597 solubility dmso of these neuropeptides. Objectives: The present study investigates the impact of BOM and GRP in the female Sprague–Dawley rats 225 g b.w. n = 37 urethras in vitro and in vivo. Intraurethral pressure was recorded by a catheter placed at the maximum pressure zone corresponding to the intrinsic urethral spincter.
Measurements: In vitro, the intraurethral pressure was measured SB203580 datasheet in response to the administration of BOM and GRP and noradrenaline from perfused intact urethral/bladder preparations. In vivo, changes in intraurethral pressure were conducted in anesthetized subjects and compared with the basal intraurethral pressure and sham controls. Results: In vitro, the increase in intraurethral pressure induced by BOM was 23.6+/-3.2cmH(2)O, exceeding the pressure evoked with NA by 10.7cmH(2)O whereas GRP induced 10.7+/-1.6cmH(2)O, an increase of 3.3cmH(2)O but less than the NA evoked intraurethral pressure by 2.2cmH(2)O. Incubation with scopolamine (1 mu M), phentolamine (1 mu M), pancuronium (1 mu M), and indomethacin (1 mu M) did not produce any significant difference in the contractile responses to BOM or GRP. In vivo, the mean basal pressure was 22.9+/-1.4cmH(2)O. The intraurethral pressure evoked by BOM was 29.7cmH(2)O (21.3+/-1.3 to 51.0+/-1.6cmH(2)O), and for GRP, the evoked intraurethral pressure was 33.8cmH(2)O (22.3+/-1.9 to 56.2+/-30cmH(2)O). Conclusions: BOM and GRP may contribute to the control of continence by their contractile action on the sphincters of the lower urinary tract outflow region. Neurourol. Urodynam. 30:1681-1685, 2011. (C) 2011 Wiley Periodicals, Inc.